" /> DNAJB1-PRKACA Fusion Kinase Peptide Vaccine - CISMeF





Preferred Label : DNAJB1-PRKACA Fusion Kinase Peptide Vaccine;

NCIt synonyms : Fibrolamellar Hepatocellular Cancer Peptide Vaccine; DNAJB1-PRKACA Peptide Vaccine; DNAJB1-PRKACA Fusion Peptide Vaccine; FLC Peptide Vaccine;

NCIt definition : A cancer peptide vaccine composed of a fusion peptide derived from the fusion protein DnaJ homolog subfamily B member 1-cAMP-dependent protein kinase catalytic subunit alpha fusion protein A (DNAJB1-PRKACA) that is encoded by the DNAJB1/PRKACA fusion gene, with potential immunomodulating and antineoplastic activities. Upon administration, the DNAJB1-PRKACA fusion kinase peptide vaccine may induce CD8 T cell- and CD4 T cell-mediated immune response against tumor cells expressing the DNAJB1-PRKACA fusion protein, which may result in the inhibition of proliferation in these tumor cells. The DNAJB1-PRKACA fusion protein is expressed in all fibrolamellar carcinoma (FLC) tumors and plays a key role in FLC tumorigenesis.;

NCI Metathesaurus CUI : CL1648307;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
10/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.